Akzo Nobel N.v.

Akzo N.v.

Johannes A Claessens

Paulus Jacobus Sondermeijer

Robin Wilson Morgan

Albert P Mockett

Martha Jacoba Willemse

Pulus J Sondermeijer

The invention is related to a nucleic acid sequence encoding a MD06 Marek's Disease Virus protein. Such a protein can be used for the immunization of poultry against MDV infection or disease. The nucleic acid sequence encoding the MD06 MDV protein can be applied for the preparation of the protein by means of genetic engineering techniques or can be applied for the preparation of vector vaccines.

Recombinant vaccine against marek's disease

The invention is related to a nucleic acid sequence containing the genetic information of the chicken anemia virus (CAV). Especially, three genomic regions are identified encoding viral polypeptides. Said regions or polypeptides can be used for the preparation of a vaccine against CAV infection or for diagnostic purposes. The invention is also concerned with a test kit useful for the detection of CAV infected chickens.

Chicken anemia virus vaccine and diagnostic

The present invention is concerned with a recombinant Herpesvirus of Turkeys (HVT), containing a heterologous gene incorporated into an insertion region of the genome of HVT. The invention also relates to a vector vaccine comprising such a recombinant HVT which expresses a heterologous antigenic polypeptide and induces an adequate immune response on infection of an appropriate host animal.

Recombinant herpesvirus of turkeys and live vector vaccines derived

The invention is concerned with the MD18 and MD20 polypeptides of Marek's Disease virus which can be used to vaccinate poultry against MD. The invention also relates to nucleic acid sequences encoding the MD18 or MD20 polypeptides. Said sequences can be used for the preparation of a subunit or vector vaccine.

Mareks' disease virus vaccine

The present invention is concerned with a recombinant Herpesvirus of Turkeys (HVT), containing a heterologus gene incorporated into an insertion-region of the genome of HVT. The invention also relates to a vector vaccine comprising such a recombinant HVT which expresses a heterologous antigenic polypeptide and induces an adequate immune response on infection of an appropriate host animal.

Growing community of inventors

Boxmeer, Netherlands

Johannes A Claessens